jdkm, I can't remember where, but I think they make more money...

jdkm,

I can't remember where, but I think they make more money that 10c per tablet. Check out this site:

http://www.brr.com.au/asx/RBY

I think it might be around 50c per tablet - but don't quote me, DYOR.

Short term, I think the Avian Bird flu tablets will be the thing that keeps their earnings potentially positive, but long term, Pepp could do well if it works.

I came up with $1.365M - but my estimates were a little different to yours. I estimated bird flu sales of 6Mil over two years, but think the deal may be over 1 year. Here was my rationale:

http://hotcopper.com.au/post_single.asp?fid=1&tid=710805&msgno=3110698#3110698

I am hopeful that they will put on some positive results over the next 12 months and that Pepp does well. I am interested in the Pepp side of things because in my mind it has big potential - but I don't think it will be the highlight of this quarter. I have done a little investigating regarding this and will post my outcomes in another thread.

Cheers jdkm, and thanks for providing your assessment with your rationale.